Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series.

[1]  H. Castro,et al.  Trypanocidal agents with low cytotoxicity to mammalian cell line: a comparison of the theoretical and biological features of lapachone derivatives. , 2006, Bioorganic & medicinal chemistry.

[2]  L. Leon,et al.  Antileishmanial pyrazolopyridine derivatives: synthesis and structure-activity relationship analysis. , 2004, Journal of medicinal chemistry.

[3]  J. Urbina,et al.  Specific chemotherapy of Chagas disease: controversies and advances. , 2003, Trends in parasitology.

[4]  J. Périé,et al.  Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. , 2003, Biochemical pharmacology.

[5]  J. Dias,et al.  The impact of Chagas disease control in Latin America: a review. , 2002, Memorias do Instituto Oswaldo Cruz.

[6]  J. Urbina.  Specific treatment of Chagas disease: current status and new developments , 2001, Current opinion in infectious diseases.

[7]  B. Insuasty,et al.  Reaction of 5-aminopyrazoles with β-dimethylaminopropiophenones. Synthesis of new pyrazolo[3,4-b]pyridines , 1998 .

[8]  Misbahul Ain Khan,et al.  Pyrazolo[3,4-b]pyridines: Syntheses, reactions, and nuclear magnetic resonance spectra , 1988 .

[9]  Misbahul Ain Khan,et al.  HETARYLPYRAZOLES. IV. SYNTHESIS AND REACTIONS OF 1,5′‐BIPYRAZOLES , 1983 .

[10]  L. Leon,et al.  Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N'-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides. , 2006, European journal of medicinal chemistry.

[11]  A. Jansen,et al.  The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi. , 1997, Microbios.